Foods & Inns Q1 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
No
Order
No
Capex
Yes
1 of 5 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- Volume growth for the current fiscal year is expected around 15% to 20% on an annualized basis, although Q1 was impacted by unseasonal rains and the beverage industry's slower growth. (Page 13-14)
- Company remains hopeful to recover substantially in the next 8-9 months and regain the anticipated growth trajectory. (Page 14)
- Revenue growth is driven by increased production, especially a 40% higher mango pulp production than the previous season, which will be dispatched over 12-15 months. (Page 7)
- Realization per kg is expected to vary with mango varieties, some higher and some lower, balancing overall revenue. (Page 13)
- Expansion into other fruit and vegetable pulps is targeted to reduce dependency on mango pulp from 85% revenues closer to 50-60% in the coming years. (Page 6)
- New product launches like Tetra Recart and ready-to-eat categories expected to add to future revenues, with trials and commercial scaling ongoing. (Page 9)
- Asset turns for new CAPEX projects anticipated at around 3x to boost revenue growth. (Page 12)
See what Foods & Inns management said on margin guidance — free account, 30 seconds.
Fundraise plans
No- Currently, there are no active plans for new equity fundraising; a recent planned fundraise has been deferred as the opportunity did not materialize.
- Previous equity warrants issued in December 2022 are in process, with investors partially converting them into equity; full subscription expected by June 2024.
- Future equity raising will depend on value-accretive opportunities arising in the market.
- Regarding promoter shareholding, there are plans being considered with a timeline until June next year; no dilution is expected from these promoter plans as they may be non-dilutive.
- No specific mention of new debt fundraising; existing working capital needs are supported by increased production, leading to increased working capital borrowings and finance costs, but no new debt plan announced.
- Overall, fundraising activities are opportunistic and contingent on market conditions and value propositions.
See what Foods & Inns management said on order book — free account, 30 seconds.
Capex plans
Yes- Foods & Inns plans a total CAPEX of around Rs. 40-50 crores for the current fiscal year, already funded through equity.
- For FY25, no major CAPEX planned except for spray drying capacity expansion and tomato processing plant.
- The company expects a minimum asset turnover of around 3x from the current CAPEX investments.
- A tomato concentrate plant is planned, expected to start production from October.
- The pectin manufacturing project is slightly delayed but expected to start by end of September 2023.
- Expansion in export markets (e.g., for Kusum spices) to mitigate export risks and diversify.
- Strategic focus on launching new SKUs (6 ready-to-cook SKUs under Tetra Recart packaging) and increasing presence in frozen fruits and vegetable segments.
- Exploring opportunities for copacking with large brands, targeting revenue growth from Q4 FY24 onwards.
Track Foods & Inns — get its next earnings analysis in your feed
How does Foods & Inns rank vs peers in Food Products?
Pro featureHow does Foods & Inns rank in Food Products?
Compare Foods & Inns against every Food Products company (Q1 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Foods & Inns's management said in earlier quarters
Others in Food Products this season
- Sheetal Cool Products Ltd (Q1 FY27)
Revenue from Operations for FY26: ₹366.0 Crores, up 13.9% YoY from ₹321.3 Crores in FY25 (Page 29, 5). Key investor presentation takeaways from Sheetal Cool Pro
- Mukka Proteins Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Mukka Proteins Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹489.7 crore . Key concall takeaways from Mukka Proteins Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Shri Ahimsa Naturals Ltd (Q4 FY26)
Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.